Abstract: The invention concerns an exchanger-reactor (1) comprising: a vessel (2); means for distributing a feed through a fixed bed catalytic zone (10); means (6) for collecting effluent from the catalytic zone (10); means for heating the catalytic zone (10); in which said collection means (6) comprise conduits passing right through the catalytic zone (10), said conduits being distributed in the catalytic zone and interposed between the heating means, and in which the heating means of the catalytic zone are contained in sheaths (8) which are partially immersed in the catalytic zone (10), the sheaths (8) being open at one of their ends and closed at the other, the open end being fixed to an upper tube plate (21) defining the collection chamber (19) which is located above the catalytic zone (10), said heating means comprising at least one combustion zone (13) located close to the catalytic zone, means for supplying said combustion zone (13) with an oxidizing gas mixture (15) and with a gaseous fuel (17), and means

Abstract: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A is a carbocycle or heterocycle; X is alkylene, NR4C(O), NR4C(S), NR4C(NH), NR4SO, NR4SO2, NR4C(O)NH, NR4C(S)NH, C(O)NR4, C(S)NR4, C(NH)NR4, NR4PO or NR4PO(OH) wherein R4 is H or alkyl; R1 is selected from the group consisting of alkyl, cycloalkyl, aryl or a heterocycle each of which is optionally substituted with hydroxy, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; R2 is halogen, hydroxy, alkyl, acyl or alkoxy each optionally substituted with hydroxy, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; R3 is halogen, hydroxy, alkyl, acyl or alkoxy each optionally substituted with hydroxy, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy; m is 0-3; n is 0-3; and salts and solvates thereof.

Abstract: The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the ?7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Abstract: The method allows liquefaction of a dry natural gas comprising water and heavy hydrocarbons containing more than five carbon atoms. The following stages are carried out: a) passing the dry natural gas through a water-adsorbent solid so as to obtain a water-depleted natural gas and a water-laden adsorbent solid, b) passing the water-depleted natural gas through a solid adsorbing heavy hydrocarbons comprising at least five carbon atoms so as to obtain a heavy hydrocarbon-depleted natural gas and a heavy hydrocarbon-laden adsorbent solid, c) liquefying the heavy hydrocarbon-depleted natural gas at a pressure above 40 bar abs so as to obtain a liquid natural gas under pressure, d) expanding the liquid natural gas under pressure obtained in stage c) to atmospheric pressure so as to obtain a liquid natural gas and a gas fraction.

Abstract: Disclosed are novel liquid-crystal compounds, processes and intermediates for the preparation thereof, the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, and to LC media and LC displays containing the same.

Abstract: The invention relates to thiophene-imidazopyridine compounds according to formula (I), wherein the substituents and symbols are as defined in the description. The compounds are inhibitors of PIk1.

Abstract: The present invention relates to pearlescent pigments based on glass flakes which are distinguished by the fact that they have the following layer structure: A) optionally a layer of SiO2, B) a high-refractive-index coating have a refractive-index n>1.8 which essentially consists of TiO2, C) a low-refractive-index layer comprising SiO2 and/or Al2O3 and optionally D) an outer protective layer, and to the use thereof in paints, coatings, automobile paints, powder coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, paper, in toners for electrophotographic printing processes, in seed, in greenhouse sheeting and tarpaulins, as absorbers in the laser marking of paper and plastics, as absorbers for the laser welding of plastics, in cosmetic formulations, for the preparation of pigment pastes with water, organic and/or aqueous solvents, for the preparation of pigment compositions and dry preparations.

Abstract: The present invention relates to the use of compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, for the development of UV-A or UV-B protection during use, to corresponding novel compounds and compositions, and to corresponding processes for the preparation of compounds and compositions.

Abstract: The present invention relates to dielectrically positive liquid-crystalline media comprising one or more compounds of the formula I in which the parameters have the meaning indicated in the specification, and optionally one or more compounds selected from the group of the compounds of the formulae II and III in which the parameters have the meaning indicated in the specification, and optionally one or more compounds of the formula IV in which the parameters have the meaning indicated in the specification, and to liquid-crystal displays containing these media, especially to active-matrix displays and in particular to TN, IPS and FFS displays.

Abstract: The present invention relates to salts having thiouronium or uronium cations, to processes for the preparation thereof, and to the use thereof as ionic liquids.

Abstract: The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.

Abstract: The present invention relates to the use of tetrahydro- and dihydroquinazolinones of formula I as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases, their use for the manufacture of a pharmaceutical composition and new tetrahydro- and dihydroquinazolinones.

Abstract: The invention relates to a snowboard binding with a sole-plate which is to be fastened on the surface of a snowboard and to which, firstly, an instep element is fastened or coupled, which instep element can be adjusted between a clamping position and a release position and by means of which the upper side of a shoe, which can be accommodated in the snowboard binding can be partially embraced, and to which, secondly, a leg support is pivotably coupled, which leg support can be pivoted between a rear entry position and a front travelling position with control means provided by means of which a pivoting movement of the leg support into the entry position is coupled at least in some sections to an adjustment movement of the instep element from the clamping position into the release position.

Abstract: The present invention relates to the preparation and use of variants of the group 1 allergens of the Poaceae (sweet grasses) which are characterised by reduced IgE reactivity compared with the known wild-type allergens and at the same time by substantially maintained reactivity with T-lymphocytes. These hypoallergenic allergen variants can be employed for the specific immunotherapy (hyposensitisation) of patients having grass pollen allergy or for the preventive immunotherapy of grass pollen allergies.

Abstract: In carton packaging having an outer folding carton and an inner folding carton which surrounds a film internal container, the inner folding carton is adhesively bonded by means of one of its carton body walls (14) to an adjacent carton body wall (6) of the outer folding carton. The outer folding carton and the inner folding carton surround the film internal container essentially completely. The film internal container consists of a flexible film internal bag provided with a withdrawal closure. The carton body walls (13, 14, 15, 16) of the inner folding carton are connected to one another in a foldable manner at the body edges (17, 18, 19, 20) via carton bridges, each bridging an edge slot. The lid flaps of the inner folding carton are angled in the finished carton packaging. The inner folding carton and the outer folding carton consist of a joint carton blank or each consist of a separate carton blank or each consist of a plurality of carton blanks.

Abstract: The instant invention relates to dielectrically positive nematic media comprising one, two or more compounds of formula I one or more compounds selected from the group of formulae II and III and one or more compounds selected from the group of formulae IV and V wherein the parameters are as defined in claim 1 with the proviso that the media comprise one or more compounds of formula III, wherein n and o both are 1 and all rings are 1,4-phenylene, which independently of each other optionally are fluorinated once or twice, and/or one or more compounds of formula V, wherein q is 2, as well as to liquid crystal displays comprising these media, especially to TN-displays and in particular to active matrix displays.

Abstract: The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the ?7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

Abstract: An object of the invention is to provide a TFT substrate and a method for producing a TFT substrate which is capable of drastically reducing the production cost by decreasing the number of steps in the production process and improving production yield. A TFT substrate comprises: a substrate; a first oxide layer formed above the substrate; a second oxide layer formed above the first oxide layer with a channel part interposed therebetween; a gate insulating film formed above the substrate, the first oxide layer and the second oxide layer; a gate electrode and a gate wire formed above the gate insulating film.

Abstract: The invention relates to the subjects characterized in the patent claims, namely metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use, processes for their preparation and their use in NMR and X-ray diagnosis, radiodiagnosis and radiotherapy, and in MRT lymphography.

Abstract: The invention relates to a plastic film, at least one side of which is provided with a surface structure comprising parallel rows of elevations (a). Said elevations (a) are interconnected by means of webs (b) that are at least 10 percent lower than the elevations (a). The inventive films can be used for producing laminated glass.